Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Noom vs Tablet Health

Noom and Tablet Health both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Noom logo

Noom

6.9
★★★★☆3.5/5

Best for: coaching bundled into the price rather than sold separately

Visit Noom →
VS
Tablet Health logo

Tablet Health

5.8
★★★☆☆2.9/5

Best for: seeing what it charges before you answer any medical questions

Visit Tablet Health →

If you are choosing between Noom and Tablet Health, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Noom leads our six-part score, 6.9 to 5.8.

Noom vs Tablet Health price

Noom and Tablet Health start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at Tablet Health ($199 a month vs $349 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Noom prices compounded injections and brand-name pens, while Tablet Health prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.

Where each one treats patients

Neither Noom nor Tablet Health publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Noom

GLP-1Rx Program, compounded semaglutide (medication included)Compounded
$349$149/mo
Save 57% right now
semaglutide

The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.

GLP-1Rx Program — brand tirzepatide (Zepbound/Mounjaro)Brand-name
$349/mo
tirzepatide
Microdose GLP-1Rx, compounded semaglutide (medication included)Compounded
$179$79/mo
Save 56% right now
semaglutide

The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.

Tablet Health

Starting (dose tier unpublished)Compounded
$199/mo
semaglutide
Starting oral (dose tier unpublished)Compounded
$179/mo
semaglutide
Starting (dose tier unpublished)Compounded
$299/mo
tirzepatide
Starting oral (dose tier unpublished)Compounded
$199/mo
tirzepatide

What each price covers

Noom's price also covers the clinician visit and coaching, which Tablet Health does not claim.

Tablet Health's price also covers the medication itself, which Noom does not claim.

Noom is silent on the medication itself, shipping and lab work.

Tablet Health is silent on the clinician visit, shipping, lab work and coaching.

That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.

Noom

Covered by the monthly price

Medication

Not stated

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Tablet Health

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Noom scores 6.9 and Tablet Health 5.8 out of 10.

Noom is stronger on value (5.2 vs 3.0) and trust & safety (6.5 vs 2.5).

Tablet Health is stronger on support (5.0 vs 4.0).

Effectiveness, user experience and accessibility are within half a point.

How we score

Noom

6.9/10

Overall

Tablet Health

5.8/10

Value25%

5.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
2.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

4.0A
vs
B
5.0

FDA warning letters

Neither Noom nor Tablet Health has an FDA warning letter on record with us.

Features & Coverage

FeatureNoomTablet Health
Starting Price$179/mo$179/mo
Features2 features✓5 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Noom

Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.

Read our full Noom review →

About Tablet Health

Semaglutide in oral form opens at $179/mo, injected tirzepatide at $299/mo, and a subscriber can cancel whenever. Both molecules are sold as injections and as orals, the oral GLP-1 being rare in this market, and ED and NAD+ wellness lines run alongside. Tablet Health is LegitScript Certified and identifies four compounding pharmacies it works with, more disclosure than most give.

Read our full Tablet Health review →

Pros & Cons

Noom

What we like

  • Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits and coaching
  • We found no FDA warning letters issued to Noom

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Tablet Health

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • We found no FDA warning letters issued to Tablet Health

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Noom

Noom wins this one, 6.9 to 5.8, above all for coaching bundled into the price rather than sold separately. Tablet Health fits better if seeing what it charges before you answer any medical questions is your priority.

Choose Noom if…

You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.

Choose Tablet Health if…

You want seeing what it charges before you answer any medical questions and an opening price near $179 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.1

DudeMeds

Compounded semaglutide at $175/month

7.8

Oak

Semaglutide at $119/month, 37% below the typical price

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

Noom vs Tablet Health: FAQ

Neither on the entry price: Noom and Tablet Health both start at about $179 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Noom does not publish where it ships; Tablet Health does not publish where it ships. Confirm your state before paying.
Only Noom includes the clinician visit and coaching. Only Tablet Health includes the medication itself.
Noom has none. Tablet Health has none.
No. Neither Noom nor Tablet Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.